[…] American lives are at stake! Money- coming in! Deployment of troops Healthcare workers Mobile laboratories Mobilizing global resources Contain Ebola in West Africa to stop it spreading to USA & Europe!! Need 5000 more HCWs! International Support since April 2014 Not very clearly documented Chinese CDC = 7500 HCW- laboratories, IPC Cuba = 600 approximately African HCW= 8000 sent by AU UK = 750 HCW,...
Type: Media
[…] . 20(1): pp 39 -53. 21. Orsted, H., et al. (20 11). Basic principle s of wound healing. Wound Care Canada . 9(2):4 – 12. 22. Phillips, P., et al. (2010). Biofilms made easy. Wounds International . 1:1 -6. Retrieved from www.woundsinternational.com/pdf/content_8851.pdf 23. Ramundo, J., et al. (2009). Collagenase for debridement: A systematic review. Journal of Wound Ostomy Continence Nursing. 36(6): S4 – S11. 24. Rietschel,...
Type: Media
[…] was establis hed to monitor the incidence and trends of healthcare - associated CDI among patients who have been hospitalized in acute care facilities . Clostridium difficile or C. difficile is a germ that can live in the bowel without causing harm. However, if the normal bacteria in the gut are destroyed by taking certain antibiotics in high doses or over a prolonged period of time,...
Type: Media
[…] RESOURCES Kate Gase, BJC Learning Institute, St. Louis May 16 ( FREE Teleclass - Broadcast live from the 2016 IPAC-Canada conference) PHYSICIANS, FARMERS, AND THE POLITICS OF ANTIBIOTIC RESISTANCE Dr. Laura H. Kahn, Woodrow Wilson School of Public and International Affairs, Princeton University Sponsored by Virox Technologies Inc. (www.virox.com) May 17 ( FREE Teleclass - Broadcast live from the 2016 IPAC-Canada conference...
Type: Media
[…] provincial CDI surveillance program was established to monitor the incidence and trends of healthcare - associated CDI among patients who have been hospitalized in acute care facilities. Clostridium difficile (C. difficile) are bacteria that can live in the bowel without causing harm. For healthy people, C. difficile does not often pose a health risk. However, for people taking antibiotics or with weakened immune system s, e.g....
Type: Media
[…] CDI surveillance program was established to monitor the incide nce and trends of healthcare- associated CDI among patients who have been hospitalized in acute care facilities . Clostridium difficile (C. difficile) are bacteria that can live in the bowel without causing harm. For healthy people, C. difficile does not often pose a health risk. However, for people taking antibiotics or with weakened immune system s, e.g....
Type: Media
[…] surveillance program was established to monitor the incidence and trends of healthcare - associated CDI among patients who have been hospitalized in acute care facilities . Clostridium difficile (C. difficile) is a bacterium that can live in the bowel without causing harm. For healthy people, C. difficile does not often pose a health risk. However, for people taking antibiotics or with weakened imm une system s,...
Type: Media
[…] provincial CDI surveillance program was established to monitor provincial incidence and trends of healthcare-associated CDI among patients who have been hospitalized in acute care facilities . Clostridium difficile (C. difficile) is a bacterium that can live in the bowel without causing harm. For healthy people, C. difficile does not often pose a health risk. However, for people taking antibiotics or with weakened immune systems, e.g. patients...
Type: Media
[…] has mandated simulation as part of its maintenance of certification program since 2000. It’s category 3 in our MOC according to RC. It is likely that simulation will play an increasing role in recertification activities. Video 1 This is a sample video of a simulation based activity. Video 2 This is a sample video of a simulation based activity that...
Type: Media
[…] (Q1) of 2021/22 (April 1 – June 24, 2021) Carbapenemase-Producing Organisms (CPO) Comparisons across health authorities should be avoided due to variations in population at risk and screening policy for CPO. * With surveillance information available ** Exposures are not mutually exclusive Target compliance Compliance in ACF Compliance in LTCF 70 75 80 85 90 95 Q1 Q2Q3 Q4 Q1Q2Q3 Q4 Q1Q2Q3 Q4 Q1Q2Q3 Q4 Q1Q2Q3 Q4 2017/18 2018/192019/202020/212021/22 Percent Compliance ACF...
Type: Media
[…] Refer to your organizational procedures for additional precautions, or to Public Health Agency of Canada’s Routine Practices and Additional Precautions for Preventing the Transmission of Infection in Healthcare Settings guidance. Refer to PICNet video resources for donning and doffing personal protective equipment For further consultation and b efore discontinuing airborne, droplet and contact precautions , contact IPC in health authority -operated sites and...
Type: Media
[…] (Q2) of 2021/22 (June 26 – September 16, 2021) Carbapenemase-Producing Organisms (CPO) Comparisons across health authorities should be avoided due to variations in population at risk and screening policy for CPO. * With surveillance information available ** Exposures are not mutually exclusive Target compliance Compliance in ACF Compliance in LTCF 70 75 80 85 90 95 Q1 Q2Q3 Q4 Q1Q2Q3 Q4 Q1Q2Q3 Q4 Q1Q2Q3 Q4 Q1Q2Q3 Q4 2017/18 2018/192019/202020/212021/22 Percent Compliance ACF...
Type: Media
[…] (September 17– December 9, 2021) Carbapenemase-Producing Organisms (CPO) Comparisons across health authorities should be avoided due to variations in population at risk and screening policy for CPO. * With surveillance information available ** Exposures are not mutually exclusive Community care settings 0 Target compliance Compliance in ACF Compliance in LTCF ACF 91% LT C F 89% ACF 77% LT C F 86% ACF 79% LT C F 89%...
Type: Media
[…] 10, 2021 – March 31, 2022) Carbapenemase-Producing Organisms (CPO) Comparisons across health authorities should be avoided due to variations in population at risk and screening policy for CPO. * With surveillance information available ** Exposures are not mutually exclusive 59 new cases Identified from 50 patients • 41 patients harboured 1 gene • 9 patients harboured 2 genes NDM Most commonly identified gene 18 of 49 new cases (With...
Type: Media
[…] (June 24 – September 15, 2022) Carbapenemase-Producing Organisms (CPO) Comparisons across health authorities should be avoided due to variations in population at risk and screening policy for CPO. * With surveillance information available ** Exposures are not mutually exclusive 73 new cases Identified from 65 patients • 57 patients harboured 1 gene • 8 patients harboured 2 genes NDM Most commonly identified gene 17 of 60 cases (With surveillance...
Type: Media
[…] (April 1 – June 23, 2022) Carbapenemase-Producing Organisms (CPO) Comparisons across health authorities should be avoided due to variations in population at risk and screening policy for CPO. * With surveillance information available ** Exposures are not mutually exclusive Number of new CPO cases identified with available surveillance information, Q1 of 2022/23 (n = 65 cases) * Community care settings 0 Target compliance Compliance in ACF Compliance in LTCF...
Type: Media
[…] (September 16 – December 8, 2022) Carbapenemase-Producing Organisms (CPO) Comparisons across health authorities should be avoided due to variations in population at risk and screening policy for CPO. * With surveillance information available ** Exposures are not mutually exclusive 89 new cases Identified from 77 patients • 65 patients harboured 1 gene • 12 patients harboured 2 genes NDM Most commonly identified gene 23 of 69 cases (With surveillance...
Type: Media
[…] 9, 2022 – March 31, 2023) Carbapenemase-Producing Organisms (CPO) Comparisons across health authorities should be avoided due to variations in population at risk and screening policy for CPO. * With surveillance information available ** Exposures are not mutually exclusive Exposure information ** for new CPO cases, Q4 of 2022/23 (n = 115 cases) * Comparisons across health authorities and facility types should be avoided due to potential observer bias,...
Type: Media
[…] by gene classification, Q1 of 2023/24 (identified from 107 new patients) (n = 130) Quarter one (Q1) of 2023/24 (April 1 – June 22, 2023) Carbapenemase-Producing Organisms (CPO) * With surveillance information available ** Exposures are not mutually exclusive Number of new CPO cases identified with available surveillance information, Q1 of 2023/24 (n = 112 cases) * Exposure information ** for new CPO cases, Q1 of 2023/24 (n =...
Type: Media
[…] environment •Prometric is a U.S. based company in the test administration industry and provides test development and delivery services https://www.prometric.com/ Candidate Testing Experience•Candidates can take the exam at a physical testing center or via Prometric’s live remote proctoring option, Pro Proctor •Te s t i n g i s a v a i l a b l e 5-7 days a week depending on location Prometric...
Type: Media